Core Viewpoint - Synthomer expects a decline in sales and profits for the year 2025 compared to 2024 due to weak end-market demand and global tariff changes since the second quarter of last year [1] Financial Performance - The company projects annual sales of approximately £1.74 billion for 2025, down from £1.93 billion in 2024 [1] - Earnings before interest, taxes, depreciation, and amortization (EBITDA) are expected to be between £135 million and £138 million, lower than the previous year's £143 million [1] Operational Strategy - Despite the overall sales decline, the company has managed to achieve resilient profit performance and improved profit margins through enhanced operational execution and cost reduction initiatives [1] - The CEO, Michael Willome, indicated that the company has expanded its cost-saving measures and accelerated the transformation towards specialty solutions in its business portfolio [1] Business Segments - The coatings and construction solutions segment is a key area for cost reduction implementation [1] - The adhesives solutions segment is recovering market share and improving profit margins due to capacity investments in Texas [1] - The health and protection business saw a rebound in customer demand in the fourth quarter, although its profit margins remain significantly below pre-pandemic levels [1] Future Outlook - Looking ahead to 2026, the company anticipates potential year-on-year improvements even if the market does not show significant recovery [2]
昕特玛预计2025年业绩下滑
Zhong Guo Hua Gong Bao·2026-02-04 03:20